MGAT2 inhibitor

SI-6817

MGAT2 inhibitor, >98% (HPLC)

IUPAC Name : Ethyl 3-(4-((3-(2-(cyclohexylthio)-4-oxo-3-phenyl-3,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine-6-carbonyl)azetidin-1-yl)methyl)phenyl)propanoate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : A monoacylglycerol acyltransferase‑2 (MGAT2) inhibitor developed for metabolic disease and NASH research, supporting studies on lipid absorption, energy homeostasis, and hepatic steatosis.

References : Turdi H. et al.: J. Med. Chem., 64(19), 14773-14792, 2021; Cheng D. et al.: Cell Metab., 34(11), 1732-1748.e5, 2022.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.